New York, NY, United States of America

Axel Heinemann

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Axel Heinemann in Cerebral Ischemia Treatment

Introduction

Axel Heinemann is an innovative inventor based in New York, NY (US). He has made significant contributions to the field of medical technology, particularly in the treatment of cerebral ischemia. His work focuses on improving patient outcomes through advanced systems and methods.

Latest Patents

Heinemann holds a patent for a system and method aimed at improving outcomes following cerebral ischemia. This system includes a source of nitric oxide and an elongate tubular member designed for insertion into the nose. The tubular member features at least one orifice and is connected to the nitric oxide source, allowing for the delivery of the gas into the nasal cavity. This method facilitates absorption into the cerebral vasculature through the nasal vasculature. Additionally, the system includes a device for controlling the flow and concentration of nitric oxide.

Career Highlights

Heinemann's career is marked by his dedication to advancing medical technology. His innovative approach to treating cerebral ischemia showcases his commitment to improving healthcare outcomes. He works at Astuce, Inc., where he continues to develop and refine his inventions.

Collaborations

Heinemann collaborates with notable colleagues, including Denise R Barbut and Allan Rozenberg. Their combined expertise contributes to the success of their projects and innovations.

Conclusion

Axel Heinemann's work in developing a system for treating cerebral ischemia highlights his role as a key innovator in medical technology. His contributions are paving the way for improved patient care and outcomes in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…